Luc Debruyne is president of global vaccines at GSK, a position he was appointed to in 2013. He joined GSK in 1991 and worked as a commercial strategy director in R&D, and since then has served in multiple capacities in many countries. Prior to his current role, he was appointed senior vice president of GSK Pharma Europe in 2012. Debruyne is a member of the IFPMA Vaccines CEO Roundtable and of the Belgian Federation of Enterprises’ management committee. He has previously co-chaired the EFPIA and has been a member of the board of Italy’s Farmindustria and its equivalent in The Netherlands, NEFARMA.
Previously
Infectious diseases represent one of the greatest threats to global health and security. The failures of the Ebola crisis demonstrated that we remain woefully unprepared, but...